MyAverix Finance MyAverix Finance

LSE

Xeris Biopharma Holdings, Inc. (0A8E)

Xeris Biopharma Holdings, Inc. (0A8E) is listed on LSE. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 0A8E

P/E ratio
18.00

Xeris Biopharma Holdings, Inc. (0A8E) — FAQ

What is 0A8E's P/E ratio?

The price-to-earnings (P/E) ratio for Xeris Biopharma Holdings, Inc. (0A8E) is 18.00 (data as of 2026-05-23).

Does Xeris Biopharma Holdings, Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Xeris Biopharma Holdings, Inc. (0A8E). Check the MyAverix Finance app for the latest dividend data.

What exchange is 0A8E listed on?

0A8E is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play